PositiveID's Implantable Microchip
Microchip Implant to Link Your Health Records, Credit History, Social Security
As this presentation to investors makes clear, the chip and its database could form the basis of a new national identity database lined to Social Security and NationalCreditReport.com.The VeriMed Health Link homepage describes the chip:
… a tiny, passive microchip (the nation’s first and only microchip cleared for patient identification by the U.S. Food & Drug Administration) and a secure, private online database that links you to your personal health record. Your Health Link is always with you and cannot be lost or stolen.That database can be accessed by doctors and nurses:
About the size of a grain of rice, the microchip is inserted just under the skin and contains only a unique, 16-digit identifier. The microchip itself does not contain any other data other than this unique electronic ID, nor does it contain any Global Positioning System (GPS) tracking capabilities. And unlike conventional forms of identification, the Health Link cannot be lost, stolen, misplaced, or counterfeited. It is safe, secure, reversible, and always with you.But VeriChip’s ambitions don’t end there, as this diagram indicates:
(Click to enlarge.)
Yes, it shows your Health Link chip linked to Google, Microsoft, employers and insurers. The company also sees the VeriMed Health Link linked to your “identity security services,” through a separate VeriChip product, PositiveID. This slide show states:
PositiveID puts people in control of their personal health records and financial information, bridging the gap between secure medical records and identity securityPositiveID dovetails with Health Link:
Cross marketing opportunities: cross-sell the NationalCreditReport.com customer base the Health Link personal health record and vice-versa
Differentiates PositiveID as the only personal health record that offers identity theft protectionIt’s a future in which your doctor tags you like a dog with a microchip that allows anyone with the right privileges to look at your medical records, credit history, social security number (see slide 6), and anything else that stems from that.
Suddenly, storing medical records on paper in locked cabinets inside a single doctor’s office starts to look like something we may not want to rush to give up.
Microchip Implant: Mark of the Beast or the Coming 'Singularity'?
October 9, 2009And he causeth all, both small and great, rich and poor, free and bond, to receive a mark in their right hand, or in their foreheads:
And that no man might buy or sell, save he that had the mark, or the name of the beast, or the number of his name.
Here is wisdom. Let him that hath understanding count the number of the beast: for it is the number of a man; and his number is Six hundred threescore and six.The suggestion is that if the government starts requiring chip implants, then this will be a sign that the antichrist is in charge and we’re at the end of days. (Of course, the beast in question will have “two horns like a lamb, and he spake as a dragon,” which should be easy to spot in a presidential candidate.)
On the other hand, the singularity buffs see nothing but good news. There’s an obvious advantage on the club scene, as VeriChip could replace both photo ID and cash:
More importantly, the chip that increases your compliance with your prescription — so you don’t stop taking them before the full course of pills is up — will only improve public health, the singularitarians believe:Beautiful club-goers have a problem: If you’re going to wear a halter top and micro-skirt, there’s not much of anywhere to put a wallet. And who wants to carry a purse when you’re there to dance? Luckily, a company called VeriChip this year unveiled a solution based on radio-frequency identification (RFID) technology.
Raisin, or any system that helps us discipline our health habits is bound to help us live longer and happier. That’s the promise of Body 2.0 and I hope that the partnership between Proteus and Novartis means that promise is gaining ground in the global marketplace.And finally: Proteus CEO Andrew Thompson believes his company’s market opportunity could be $100 billion. This is delusional. The serious debate here is over privacy and tracking concerns, and whether anyone might be required to have an implant. The vast majority of patients and consumers simply won’t want one.
IBM Builds ‘Bar Code Reader’ for DNA
October 6, 2009Fox News - Imagine a diet tailored to the precise speed of a person's metabolism. Using a little microelectronics, a little physics, and no small dose of biology, IBM has brought that futuristic world a little bit closer.
The DNA Transistor is a project from IBM Research that aims to advance personalized medicine, by making it simpler (and much cheaper) to read an individual's unique DNA sequence — the special combination of proteins that makes you unlike anyone else.
The technology isn't finished yet, but its potential is tantalizin enough that IBM wanted to share it with the world. And the company claims researchers are making progress.
Essentially a bar code reader for genes, the DNA Transistor is part technique and part device. It consists of a 3-nanometer wide hole, known as a nanopore, in a silicon microchip. A sensor in the pore can read DNA and determine its unique makeup.
The challenge scientists face is controlling the rate at which a strand moves through that nanopore: A DNA molecule needs to spend enough time in it for the sequencing to work. By cycling voltages to the transistor's poles, IBM aims to move the DNA through the nanopore at a consistent rate one nucleotide (molecule of DNA) at a time.
The company's researchers are currently investigating various housings for the pore as well, honing the multilayer (metal and dielectric) nano-structures to move samples through more evenly.
“The technologies that make reading DNA fast, cheap and widely available have the potential to revolutionize bio-medical research and herald an era of personalized medicine,” said IBM research scientist Gustavo Stolovitzky. “Ultimately, it could improve the quality of medical care by identifying patients who will gain the greatest benefit from a particular medicine and those who are most at risk of adverse reaction.”
No comments:
Post a Comment